rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer

Fang Wang; Dehui Yan; Xu Ji; Jun Han; Meijun Chen; Hong Qiao; Shaojun Zhang

doi:10.18632/oncotarget.9324

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer

Fang Wang, Dehui Yan, Xu Ji, Jun Han, Meijun Chen, Hong Qiao and Shaojun Zhang _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:41336-41345. https://doi.org/10.18632/oncotarget.9324

Metrics: PDF 1521 views | HTML 2022 views | ?

Abstract

Fang Wang1,*, Dehui Yan1,*, Xu Ji2,*, Jun Han3, Meijun Chen3, Hong Qiao3, Shaojun Zhang1

1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China

2Department of Otolaryngology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China

3Department of Endemic Disease, the Second Affiliated Hospital, Harbin Medical University, Harbin, 150086, China

*These authors contributed equally to this work

Correspondence to:

Shaojun Zhang, email: [email protected]

Hong Qiao, email: [email protected]

Keywords: thyroid cancer, genome-wide association studies, FOXE1, rs965513, meta-analysis

Received: November 06, 2015 Accepted: April 16, 2016 Published: May 12, 2016

ABSTRACT

Papillary thyroid cancer (PTC) is the most common type of thyroid cancer. With the rapid development of genome-wide association studies (GWAS), many genome variants associated with susceptibility to PTC have been identified, including the single nucleotide polymorphism rs965513 (9q22.33) near FOXE1. To evaluate the association between rs965513 and PTC in different ethnicities and countries, we conducted a meta-analysis using relatively large-scale samples from 23 studies (N = 163,136; 20,736 cases and 142,400 controls) by searching the PubMed and Google Scholar databases. Significant heterogeneity caused by different populations among the selected studies was observed. The A allele of rs965513 polymorphism was shown to be highly associated with risk of thyroid cancer, with odds ratios of 1.58 (95% CI 1.32–1.90) in all populations, 1.65 (95% CI 1.31–2.07)) in Caucasian populations and 1.49 in Asian populations. Compared to the dominant and recessive models, we observed the highest odds ratio (OR = 2.80, 95% CI 2.12–3.69) in the homozygous model. These results revealed that the rs965513 polymorphism is a risk factor for thyroid cancer

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9324

Publication Alerts

Research Papers:

rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer

Abstract